Sun Pharma Advanced Research Co Ltd
SPARCSun Pharma Advanced Research Co Ltd
SPARC![](https://assets.tickertape.in/sector-icons/health_care.png)
![](https://assets.tickertape.in/sector-icons/smallcap.png)
![](https://assets.tickertape.in/sector-icons/high_risk.png)
Price Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
-18.89 | 58.26 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
49.93 | 6.39 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Sun Pharma Advanced Research Company Limited is engaged in the research and experimental development on natural sciences and engineering (Pharmacy).
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 164.22 | 194.74 | 132.18 | 196.38 | 86.57 | 258.37 | 144.09 | 249.66 | 105.02 | 89.25 | ||||||||||
Raw Materials | 18.87 | 25.16 | 26.81 | 12.53 | 23.93 | 18.18 | 18.27 | 0.00 | 0.00 | 461.69 | ||||||||||
Power & Fuel Cost | 4.49 | 4.67 | 4.93 | 5.08 | 5.14 | 4.60 | 4.62 | 5.75 | 6.14 | |||||||||||
Employee Cost | 56.60 | 84.30 | 100.92 | 81.06 | 93.09 | 91.59 | 98.31 | 107.00 | 141.84 | |||||||||||
Selling & Administrative Expenses | 11.96 | 39.64 | 59.94 | 68.70 | 247.28 | 252.17 | 183.33 | 289.71 | 267.06 | |||||||||||
Operating & Other expenses | 132.56 | 149.95 | 128.27 | 166.79 | 17.39 | 21.40 | 19.47 | 50.38 | 62.60 | |||||||||||
EBITDA | -60.26 | -108.98 | -188.69 | -137.78 | -300.26 | -129.57 | -179.91 | -203.18 | -372.62 | -372.44 | ||||||||||
Depreciation/Amortization | 7.58 | 8.24 | 8.18 | 7.55 | 9.48 | 10.92 | 10.16 | 11.77 | 12.51 | 12.55 | ||||||||||
PBIT | -67.84 | -117.22 | -196.87 | -145.33 | -309.74 | -140.49 | -190.07 | -214.95 | -385.13 | -384.99 | ||||||||||
Interest & Other Items | 2.16 | 1.82 | 0.12 | 0.09 | 2.67 | 10.65 | 13.33 | 7.63 | 1.69 | 1.99 | ||||||||||
PBT | -70.00 | -119.04 | -196.99 | -145.42 | -312.41 | -151.14 | -203.40 | -222.58 | -386.82 | -386.98 | ||||||||||
Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.38 | 0.78 | ||||||||||
Net Income | -70.00 | -119.04 | -196.99 | -145.42 | -312.41 | -151.14 | -203.40 | -222.58 | -387.20 | -387.76 | ||||||||||
EPS | -2.95 | -4.92 | -7.91 | -5.67 | -11.92 | -5.77 | -7.62 | -7.46 | -11.93 | -11.95 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Investor Presentation
Investor Presentation
Annual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Sun Pharma Advanced Research Co Ltd | -18.92 | 58.26 | — |
Sun Pharmaceutical Industries Ltd | 45.08 | 6.43 | 0.75% |
Cipla Ltd | 31.71 | 4.88 | 0.80% |
Torrent Pharmaceuticals Ltd | 70.18 | 16.95 | 0.82% |
Price Comparison
Compare SPARC with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 3.01%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Sun Pharma Advanced Research Co Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Nippon India Nifty Smallcap 250 Index Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0293% | Percentage of the fund’s portfolio invested in the stock 0.13% | Change in the portfolio weight of the stock over the last 3 months 0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 240/255 (+4) |
SBI Nifty Smallcap 250 Index Fund - Direct Plan - Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0170% | Percentage of the fund’s portfolio invested in the stock 0.12% | Change in the portfolio weight of the stock over the last 3 months 0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 241/255 (+4) |
Motilal Oswal Nifty Smallcap 250 Index Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0134% | Percentage of the fund’s portfolio invested in the stock 0.12% | Change in the portfolio weight of the stock over the last 3 months 0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 241/255 (+3) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
SPARC has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Sun Pharma Advanced Research Company reports consolidated net loss of Rs 95.90 crore in the June 2024 quarter
![](https://pocket-image-cache.com/direct?url=http://www.business-standard.com/assets/web-assets/images/Business_Standard_685x385.jpg)
Net Loss of Sun Pharma Advanced Research Company reported to Rs 95.90 crore in the quarter ended June 2024 as against net loss of Rs 95.35 crore during the previous quarter ended June 2023. Sales declined 29.81% to Rs 16.81 crore in the quarter ended June 2024 as against Rs 23.95 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales16.8123.95 -30 OPM %-555.38-426.64 - PBDT-92.36-92.25 0 PBT-95.50-95.35 0 NP-95.90-95.35 -1 Powered by Capital Market - Live
Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the Company on 5 August 2024.Powered by Capital Market - Live
Sun Pharma Advanced Research loss widens to Rs 81.99 cr in March quarter
![](https://pocket-image-cache.com/direct?url=http://bsmedia.business-standard.com/_media/bs/img/article/2023-03/26/full/1679847073-2245.jpg)
Sun Pharma Advanced Research Company falls 5% as quarterly loss widens to Rs 82 crore
![](https://pocket-image-cache.com/direct?url=http://images.moneycontrol.com/static-mcnews/2023/04/pharma-1-770x433.jpg)
Sun Pharma may incur revenue loss for ransomware incident on March 2
![](https://pocket-image-cache.com/direct?url=http://bsmedia.business-standard.com/_media/bs/img/article/2020-02/21/full/1582307259-2266.jpg)
SPARC reports IT security incident, ransomware group claims responsibility
![](https://pocket-image-cache.com/direct?url=http://gumlet.assettype.com/freepressjournal/2023-02/d47e5cc9-e377-4116-a543-4455211b6139/2vubnmjcuisj_sun_pharma_logo.jpg?rect=0%2C0%2C3900%2C2048&w=1200&auto=format%2Ccompress&ogImage=true)
Volumes spurt at Sun Pharma Advanced Research Company Ltd counter
![](https://assets.tickertape.in/images/news-publishers/businessstandard.png)
Sun Pharma Advanced Research Company Ltd leads gainers in ‘A’ group
![](https://assets.tickertape.in/images/news-publishers/businessstandard.png)
Swan Energy Ltd leads losers in ‘A’ group
![](https://assets.tickertape.in/images/news-publishers/businessstandard.png)
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -11.77%, vs industry avg of 9.21%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.09% to 0.03%